Recruiting

3

612

Europe, Canada, US, RoW

ABX464, Obefazimod, Placebo

Abivax S.A.

Ulcerative Colitis

03/25

04/25

Recruiting

3

1050

Europe, Canada, Japan, US, RoW

ABX464, Obefazimod, Placebo

Abivax S.A.

Ulcerative Colitis

01/26

01/30

Recruiting

N/A

100

RoW

GE Discovery MR750 3.0t superconducting MRI

Tang-Du Hospital

Cerebrovascular Disease

11/26

12/26

Recruiting

3

248

RoW

pimavanserin tartrate, placebo

Tasly Pharmaceutical Group Co., Ltd

Parkinson's Disease Psychosis

06/25

01/26

Recruiting

N/A

96

RoW

transcutaneous electrical acustimulation at treatment sites, TEA, transcutaneous electrical acustimulation at sham sites, sham-TEA

Xijing Hospital

Ulcerative Colitis

01/25

03/25

N/A

200

RoW

antibiotic-impregnated catheter

Integra LifeSciences Corporation

Hydrocephalus

07/26

12/26

Recruiting

N/A

2000

RoW

Wan-Jin Chen, Taipei Veterans General Hospital, Taiwan, Chang Gung Memorial Hospital

Brain Calcification

12/29

12/79

Recruiting

N/A

500

RoW

Ning Wang, MD., PhD.

Charcot-Marie-Tooth Disease

12/39

12/49

Recruiting

N/A

2000

RoW

Ning Wang, MD., PhD.

Duchenne Muscular Dystrophy

12/39

12/49

Recruiting

3

12500

Europe, Canada, Japan, US, RoW

Lepodisiran Sodium, LY3819469, Placebo

Eli Lilly and Company

Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)

03/29

03/29

Recruiting

3

1300

Europe, Canada, Japan, US, RoW

TAK-279

Takeda

Plaque Psoriasis

05/26

05/26

Active, not recruiting

3

693

Europe, Canada, Japan, US, RoW

TAK-279, Placebo, Apremilast

Takeda

Plaque Psoriasis

08/25

04/26

2

236

Europe, Canada, Japan, US, RoW

LY3454738, Placebo

Eli Lilly and Company

Atopic Dermatitis

06/25

03/26

Active, not recruiting

1/2

49

RoW

Idarubicin, IDARU INJ

Konkuk University Medical Center, Chung-Ang University Hosptial, Chung-Ang University College of Medicine, Seoul National University Hospital, Ewha Womans University, Samsung Medical Center, Chonbuk National University Hospital, Pusan National University Hospital, Hanyang University Seoul Hospital, Soon Chun Hyang University

Leukemia, Myeloid, Acute

06/24

06/25

Active, not recruiting

N/A

100

Europe, US

Distal femur plates

AO Innovation Translation Center

Distal Femur Fracture

06/25

06/25

Recruiting

N/A

3000

Europe, US, RoW

Xingshun Qi

GastroIntestinal Bleeding

12/24

12/24

Active, not recruiting

4

800

RoW

Sodium Oligomannate Capsules (GV-971)

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

Alzheimer Disease

01/25

06/25

Recruiting

4

194

RoW

Icodextrin Peritoneal Dialysis Solution, Hypertonic Dextrose solution

First Affiliated Hospital, Sun Yat-Sen University, Baxter Healthcare Corporation

Peritoneal Dialysis

04/25

12/25

Completed

3

37

RoW

SAL-0951 tablets, SAL-0951 group

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Anemia

10/24

10/24

Completed

3

100

RoW

SAL-0951 tablets, SAL-0951 group, rHuEPO injection, rHuEPO group

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Anemia

06/24

06/24

Recruiting

3

688

RoW

Radical colectomy, HIPEC, Systemic chemotherapy

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University

Colorectal Cancer

04/24

04/26

3

400

RoW

SJP-0132, Placebo

Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.

Dry Eye

07/25

08/25

Recruiting

3

1500

Europe, RoW

Donanemab, (LY3002813), Placebo

Eli Lilly and Company

Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

04/27

04/27

Recruiting

2/3

216

RoW

B007, Cyclosporin Capsules

Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd

Primary Membranous Nephropathy

12/26

12/26

Completed

2

213

RoW

OT202 conc 0.5%, Investigational product, OT202 conc 0.1%, Placebo

Ocumension Therapeutics (Shanghai) Co., Ltd

Dry Eye

01/24

01/24

Recruiting

2

60

RoW

efgartigimod IV, Placebo

argenx, Zai Lab (Shanghai) Co., Ltd.

Lupus Nephritis

07/25

09/25

Not yet recruiting

2

76

RoW

Irinotecan Liposome, Irinotecan Liposome+LV/5-FU, Capecitabine

Sir Run Run Shaw Hospital, Zhejiang Cancer Hospital, RenJi Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Fujian Provincial Hospital, Ningbo No. 1 Hospital, Shaoxing People's Hospital, Southern Medical University, China, First Affiliated Hospital, Sun Yat-Sen University

Biliary Tract Carcinoma

11/26

11/26

Recruiting

2

146

RoW

Microwave ablation plus Camrelizumab, Microwave ablation

Shanghai Pulmonary Hospital, Shanghai, China

Multiple Primary Lung Cancer

09/25

09/27

Recruiting

1

16

RoW

BD111 Injection (Investigative New Drug), BD111 Lentivirus-like particles, HSV-1-erasing lentiviral particles, HELP, Triple-drugs therapy of HSV-1 stromal keratitis, Ganciclovir Ophthalmic Gel, Valacyclovir Hydrochloride Tablets, Prednisolone Acetate Ophthalmic Suspension

Shanghai BDgene Co., Ltd.

Herpes Simplex Virus Type I Stromal Keratitis

09/25

09/25

Recruiting

N/A

5000

RoW

No Intervention: Observational Cohort

First Affiliated Hospital, Sun Yat-Sen University

Lupus Nephritis (LN)

12/50

12/50

N/A

180

RoW

Peking Union Medical College Hospital

Weight Cycling, Obesity

Recruiting

N/A

70

RoW

Virtual Reality

First Affiliated Hospital, Sun Yat-Sen University

Renal Function Disorder

10/23

10/23

Recruiting

N/A

70

US

Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List

Ira Winer

Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Vulvar Cancer, Vaginal Cancer, Gestational Trophoblastic Disease

05/26

05/27

Not yet recruiting

N/A

425

RoW

Adjusting dietary structure + exercise + behavioral intervention

Peking Union Medical College Hospital

Polycystic Ovary Syndrome

08/25

08/26

Recruiting

N/A

600

RoW

Guangdong Provincial People's Hospital

IgA Nephropathy

12/24

12/24

Recruiting

N/A

100

RoW

Transbronchial lung cryobiopsy, Transbronchial lung biopsy

China-Japan Friendship Hospital

Acute Respiratory Failure, Acute Respiratory Distress Syndrome

11/25

11/25

3

3208

RoW

IVIG, Intravenous Immunoglobulins, Human, Aspirin, Acetylsalicylic acid, Prednisolone, STEROLONE

Children's Hospital of Fudan University, Jiangxi Province Children's Hospital, First People's Hospital of Hangzhou, Shengjing Hospital, The First Hospital of Jilin University, Chengdu Women's and Children's Central Hospital, Children's Hospital of Chongqing Medical University, Inner Mongolia People's Hospital, Sichuan Provincial People's Hospital, Wuhan Union Hospital, China, Third Affiliated Hospital of Zhengzhou University, Children's Hospital of Soochow University, Yuying Children's Hospital of Wenzhou Medical University, Beijing Children's Hospital, Qilu Hospital of Shandong University

Kawasaki Disease

12/25

Recruiting

2

115

RoW

VC004

Jiangsu vcare pharmaceutical technology co., LTD

Locally Advanced Solid Tumor, Metastatic Solid Tumor

01/24

06/24

Recruiting

N/A

68

RoW

Triangular Nail Placement of Femoral Neck

RenJi Hospital

Femoral Neck Fracture

01/23

08/23

Recruiting

N/A

15

RoW

interferon α-2b, arsenic trioxide, venetoclax

Zhejiang Provincial People's Hospital, First Affiliated Hospital of Zhejiang University

Tumour

12/25

12/25

Recruiting

N/A

40

RoW

Chemotherapy, Chemotherapy can be combined with targeted or immunotherapy or endocrine therapy.

Zhejiang Cancer Hospital

Metastatic Breast Cancer in the Liver

09/25

12/25

Recruiting

1

316

RoW

HSK42360

Haisco Pharmaceutical Group Co., Ltd.

Solid Tumors

08/26

07/27

Recruiting

N/A

2000

RoW

Surgery, Observation

First Affiliated Hospital of Fujian Medical University

Cerebral Cavernous Malformations

03/23

03/23

Recruiting

N/A

100000

RoW

Multi-disciplinary assessment

Beijing Tiantan Hospital

Ischemic Heart Disease, Cardiac Arrest, Atrial Fibrillation, Heart Failure, Aortic Diseases, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Cerebral Infarction, Occlusion and Stenosis of Precerebral Arteries, Occlusion and Stenosis of Cerebellar Arteries, Cerebral Aneurysm, Moyamoya Disease, Arteriovenous Malformation of Cerebral Vessels

12/32

12/32

Active, not recruiting

3

782

Canada, US

Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, Nealorin, Novoplatinum, Paraplat, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, hydroxydaunorubicin, Rubex, Laboratory Biomarker Analysis, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat

NRG Oncology, National Cancer Institute (NCI)

Breast Adenocarcinoma, Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer, Triple-Negative Breast Carcinoma

10/26

10/26

Recruiting

3

1000

Europe, Canada, US, RoW

IVA337, Lanifibranor, Placebo

Inventiva Pharma

NASH - Nonalcoholic Steatohepatitis

09/25

09/26

Recruiting

3

300

US

Bevacizumab, ABP 215, ABP-215, ABP215, Alymsys, Anti-VEGF, Anti-VEGF Humanized Monoclonal Antibody, Anti-VEGF Monoclonal Antibody SIBP04, Anti-VEGF rhuMAb, Avastin, Avzivi, Aybintio, BAT 1706, BAT-1706, BAT1706, BAT1706 Biosimilar, Bevacizumab awwb, Bevacizumab Biosimilar ABP 215, Bevacizumab Biosimilar BAT1706, Bevacizumab Biosimilar BEVZ92, Bevacizumab Biosimilar BI 695502, Bevacizumab Biosimilar CBT 124, Bevacizumab Biosimilar CT-P16, Bevacizumab Biosimilar FKB238, Bevacizumab Biosimilar GB-222, Bevacizumab Biosimilar HD204, Bevacizumab Biosimilar HLX04, Bevacizumab Biosimilar IBI305, Bevacizumab Biosimilar LY01008, Bevacizumab Biosimilar MB02, Bevacizumab Biosimilar MIL60, Bevacizumab Biosimilar Mvasi, Bevacizumab Biosimilar MYL-1402O, Bevacizumab Biosimilar QL 1101, Bevacizumab Biosimilar QL1101, Bevacizumab Biosimilar RPH-001, Bevacizumab Biosimilar SCT501, Bevacizumab Biosimilar Zirabev, Bevacizumab-adcd, Bevacizumab-awwb, Bevacizumab-aybi, Bevacizumab-bvzr, Bevacizumab-equi, Bevacizumab-maly, Bevacizumab-onbe, Bevacizumab-tnjn, BP102, BP102 Biosimilar, CT P16, CT-P16, CTP16, Equidacent, FKB 238, FKB-238, FKB238, HD204, Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer, MB 02, MB-02, MB02, Mvasi, MYL-1402O, Onbevzi, Oyavas, PF 06439535, PF-06439535, PF06439535, QL1101, Recombinant Humanized Anti-VEGF Monoclonal Antibody, rhuMab-VEGF, SCT501, SIBP 04, SIBP-04, SIBP04, Vegzelma, Zirabev, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Osimertinib, AZD 9291, AZD-9291, AZD9291, Mereletinib

National Cancer Institute (NCI)

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8

12/26

12/26

Not yet recruiting

2

200

RoW

Apatinib Mesylate +SHR-1210, Hepatic Arterial Infusion(HAI)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Hepatocellular Carcinoma

02/20

02/23

Recruiting

2

2156

US

Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Lumpectomy, Lumpectomy of Breast, Partial Mastectomy, Mastectomy, Mammectomy, Nab-paclitaxel, ABI 007, ABI-007, Abraxane, Albumin-bound Paclitaxel, Albumin-Stabilized Nanoparticle Paclitaxel, Nanoparticle Albumin-bound Paclitaxel, Nanoparticle Paclitaxel, Paclitaxel Albumin, paclitaxel albumin-stabilized nanoparticle formulation, protein-bound paclitaxel, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pertuzumab, 2C4, 2C4 Antibody, MoAb 2C4, Monoclonal Antibody 2C4, Omnitarg, Perjeta, rhuMAb2C4, RO4368451, Radiation Therapy, Cancer Radiotherapy, Irradiate, irradiated, irradiation, RADIATION, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Trastuzumab, ABP 980, ALT02, Anti-c-ERB-2, Anti-c-erbB2 Monoclonal Antibody, Anti-ERB-2, Anti-erbB-2, Anti-erbB2 Monoclonal Antibody, Anti-HER2/c-erbB2 Monoclonal Antibody, Anti-p185-HER2, c-erb-2 Monoclonal Antibody, HER2 Monoclonal Antibody, Herceptin, Herceptin Biosimilar PF-05280014, Herceptin Trastuzumab Biosimilar PF-05280014, Herzuma, MoAb HER2, Monoclonal Antibody c-erb-2, Monoclonal Antibody HER2, Ogivri, Ontruzant, PF-05280014, rhuMAb HER2, RO0452317, SB3, Trastuzumab Biosimilar ABP 980, Trastuzumab Biosimilar ALT02, trastuzumab biosimilar EG12014, Trastuzumab Biosimilar HLX02, Trastuzumab Biosimilar PF-05280014, Trastuzumab Biosimilar SB3, Trastuzumab-dkst, Trastuzumab-dttb, Trastuzumab-pkrb, Trastuzumab-QYYP, Trazimera, Trastuzumab Emtansine, Ado Trastuzumab Emtansine, ADO-Trastuzumab Emtansine, Kadcyla, PRO132365, RO5304020, T-DM1, Trastuzumab-DM1, Trastuzumab-MCC-DM1, Trastuzumab-MCC-DM1 Antibody-Drug Conjugate, Trastuzumab-MCC-DM1 Immunoconjugate

ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Invasive Breast Carcinoma, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8

10/26

12/38